Bedford, Mass., USA - January 23, 2014, Bedford, Mass., USA - Insulet Corporation, a manufacturer of tubeless insulin pumps, announced the appointment of Patrick Ryan as chief operating officer.
Article continues below
Mr. Ryan, a global supply chain expert and seasoned medical device executive, most recently served as Chief Operating Officer and President, International, of Alphatec Spine, where he was responsible for Manufacturing & Supply Chain, Research & Development, Clinical, Regulatory & Quality and International Sales & Operations.
From 2006 to 2011, Mr. Ryan worked at Abbott Vascular in key roles such as Divisional Vice President, North Asia and Divisional Vice President, Canada and Latin America. Previously, he held senior roles in Operations at Abbott Vascular, including Divisional Vice President, Worldwide Operations and Divisional Vice President, Operations, Cardiac Therapies.
Prior, Mr. Ryan served in numerous leadership positions at Guidant Corporation from 1997 to 2006, including Vice President and Managing Director, Guidant Ireland. Before his career in the medical device industry, he served in the United States Navy for 14 years.
He received a B.S. in Economics from the United States Naval Academy and a M.S. in Petroleum Management from the University of Kansas. Mr. Ryan succeeds Charles Liamos who will continue to serve as a member of Insulet's board of directors.
Mr. Liamos has served as Director since 2005. He has more than 15 years of experience in the diabetes industry, most recently serving as the Division Vice President of Abbott Diabetes Care. At Abbott, he was responsible for global finance and operations for the Diabetes Care division, including integrating the acquisitions of MediSense and TheraSense.
Prior to its acquisition by Abbott, Mr. Liamos was with TheraSense, Inc. where he served as Chief Operating Officer and Chief Financial Officer. Previously, he served as Director of Worldwide Sourcing at LifeScan, Inc., a division of Johnson & Johnson.
Mr. Liamos is also a partner in MedVenture Associates, a venture capital firm specializing in the medical technology industry where he continues to manage certain MedVentures investments as a member of the boards of three portfolio companies. ■